Notice of intent to revise BP monographs

The following monographs will be corrected as detailed in the ‘letters of intent’ below in a future edition of the BP:

Chlorhexidine Gluconate Gel

Olmesartan Tablets

Piperonyl Butoxide

Procyclidine Hydrochloride

Warfarin Tablets